The Animal Law Academy webinars are an opportunity to hone your skills and gain both practical and substantive knowledge about important issues currently facing animals in the legal system. Participants will learn from the experts and enjoy an interactive Q&A session. Don’t miss the chance to get an in-depth look into what it means to advocate for animals’ through the legal system.
Animal Law Academy webinars are suitable for anyone interested in animal law, current and future law students, attorneys, legal professionals and animal advocates.
Past webinars
Law Student Paper Series — Defining ‘Meat’: Plant-based Meat Label Censorship in the United States
Legislative Update: Spring 2021
Law Student Paper Series — Milking the System: The Ugly Truth Silenced by Ag-Gag Laws, Misleading Advertising, and Meaningless Labeling
Law Student Paper Series — The Bear Necessities: Ursine Suffering Exposed, Explained, and Expelled
Law Student Paper Series — Sustainability vs. Overexploitation: A Nexus Between Illegal Wildlife Trafficking and the Climate Crisis
Law Student Paper Series — Reducing Wildlife Mismanagement in the U.S.
Career Planning in Animal Law
Law Student Paper Series — Improving the Conservation and Protection of Sharks Through the Power of International Treaties and the Development of New Shark-Focused Legally Binding Instrument
How We Work
Related
-
Animal Legal Defense Fund Grant Supported Washington Attorney General’s Enforcement of Animal Cruelty Law
The judge sentenced a Snohomish County resident for killing then displaying neighborhood wildlife and shooting a kitten in the eye.April 18, 2024 News -
REPORT: 95 Percent of Consumers Prefer “Climate-Friendly” Products, But Labels Oversell Emission Reductions
New report reveals how misleading labels lead to increased confusion among consumers searching for more sustainable, less environmentally damaging products.April 2, 2024 Press Release -
Lawsuit Filed Demanding FDA Respond to Petitions Seeking to Ban Ractopamine
FDA’s approval for ractopamine relied primarily on safety studies conducted by the drugmaker.March 26, 2024 Press Release